A Pfizer-BioNTech booster dose will be given at least five months after the first immunization, according to FDA authorities.
Some immunocompromised children aged 5 to 11 will be able to get booster doses under the amended EUA.
Acting FDA Commissioner Dr. Janet Woodcock said in a statement that the agency has had to fast adapt to the evolving virus that causes COVID-19 because of the need to make informed decisions with the health and safety of the American public in mind throughout the pandemic.
Woodcock underlined the necessity of maintaining long-standing disease preventive practices.
This latest wave of the Omicron variety calls on us to maintain lifesaving preventative measures including primary vaccine and boosters, mask-wearing, social distancing, etc. in order to effectively battle COVID-19, she stated.